The future of American science and a dispatch from ASH

The future of American science and a dispatch from ASH










How did Terns Pharmaceuticals and its “hodgepodge” pipeline grab attention at the American Society of Hematology conference? Is Eli Lilly’s new drug making people lose too much weight? And what, exactly, is the Trump administration’s plan for reforming the National Institutes of Health?

We discuss all that and more on “The Readout LOUD,” STAT’s weekly biotech podcast. 

Read the rest…






Allison DeAngelis, Adam Feuerstein, and Elaine Chen





Go to statnews





by

Tags: